文献速递甲状腺疾病

既存精神疾病对甲状腺功能减退症患者使用碘塞罗宁的影响:一项瑞典全国队列研究

Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

该瑞典全国回顾性队列纳入2006至2020年启动甲状腺激素治疗的自身免疫性甲状腺功能减退症成人患者,采用逻辑回归模型调整性别、年龄和地区,分析既存精神疾病与后续碘塞罗宁使用之间的关联。在353708例患者中,44.8%有精神疾病史,其使用碘塞罗宁的调整比值比为1.90(95%CI 1.83-1.97,P<.001),情感或焦虑疾病者调整比值比为1.91(95%CI 1.84-1.98,P<.001),精神病性障碍无关联(调整比值比1.08,95%CI 0.98-1.19,P=.11)。

要点

  • 自身免疫性甲状腺功能减退症患者中44.8%有精神疾病史,其后续碘塞罗宁使用风险更高(调整比值比1.90)。
  • 情感或焦虑疾病与碘塞罗宁使用的关联最明显(调整比值比1.91,95%CI 1.84-1.98,P<.001)。
  • 精神病性障碍与碘塞罗宁使用无显著关联(调整比值比1.08,95%CI 0.98-1.19,P=.11)。

核心结论

  • 自身免疫性甲状腺功能减退症诊断前有精神疾病史的患者更可能接受碘塞罗宁治疗,尤其在情感或焦虑疾病患者中;这可能反映持续症状并影响甲状腺功能减退症的治疗决策。

研究设计与样本

  • 瑞典全国回顾性队列研究,纳入2006至2020年间启动甲状腺激素治疗的自身免疫性甲状腺功能减退症成人患者,数据来自国家患者登记和国家处方药登记,共353708例。

主要发现

  • 353708例患者中44.8%有精神疾病史。
  • 有精神疾病史者较无精神疾病史者更可能接受碘塞罗宁治疗(调整比值比1.90,95%CI 1.83-1.97,P<.001)。
  • 情感或焦虑疾病患者使用碘塞罗宁的关联最明显(调整比值比1.91,95%CI 1.84-1.98,P<.001)。
  • 精神病性障碍与碘塞罗宁使用无显著关联(调整比值比1.08,95%CI 0.98-1.19,P=.11)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Autoimmune hypothyroidism is a common endocrine disorder affecting 1% to 2% of the population in iodine sufficient areas. While levothyroxine is standard treatment, a substantial number of patients report persistent symptoms despite adequate treatment. The use of liothyronine as an adjunct to levothyroxine therapy has increased. The psychiatric characteristics of patients receiving liothyronine remain largely unknown. OBJECTIVE: This study examines the association between preexisting psychiatric morbidity and subsequent liothyronine use in autoimmune hypothyroidism. METHODS: This nationwide retrospective cohort study includes all adults in Sweden with autoimmune hypothyroidism and initiated on treatment with thyroid hormones between 2006 and 2020. Data were obtained from the National Patient Register and the National Prescribed Drug Register. Psychiatric morbidity prior to diagnosis was identified using ICD-10 codes and ATC codes for psychiatric medications. Logistic models estimated associations, adjusting for sex, age, and region. RESULTS: Among 353 708 patients, 44.8% had a history of psychiatric morbidity. These patients were more likely to receive liothyronine (adjusted odds ratio [aOR] 1.90, 95% CI 1.83-1.97, P < .001) than those without a psychiatric history. This was most evident among individuals with affective or anxiety morbidity (aOR 1.91, 95% CI 1.84-1.98, P < .001). No association was found for psychotic morbidity (aOR 1.08, 95% CI 0.98-1.19, P = .11). CONCLUSION: Patients with a psychiatric history before autoimmune hypothyroidism were more likely to receive liothyronine, especially among those with affective or anxiety morbidity. This may reflect persistent symptoms and affect subsequent decisions in the treatment of hypothyroidism.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Hedberg F, Lindh JD, Mannheimer B, et al. Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study. J Clin Endocrinol Metab. 2025. PMID: 40482039. doi:10.1210/clinem/dgaf337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。